I. Introduction
Patients with advanced stages of Parkinson's diseaseor dystonia that are refractory to medical management may be quite effectively treated with deep brain stimulation (DBS). MRI has distinct advantages for mapping deep brain stimulation (DBS) lead position [1] [2] [3] and postoperative function [2, 3] . However, local absorbed power during routine MRI image creation at the electrodes is several fold more than when electrode is absent in a routine head imaging, [5, 6] creating significant risks for such patients [7, 8] . DBS manufacturers [9] have labeled their devices as magnetic resonance (MR) conditional by specifying upper limits for MRI generated heating to 0.1 W/kg at 1.5 Tesla (T) and advised to use a local MRI excitation coil that does not apply power to chest electronic control system for a DBS patient (transmit/receive type head only MRI coil). The main reason for heating concern is due to the "critical length" of DBS leads (odd multiples of half wavelengths at 1.5 T), that could trigger very high and an unknown amount of local heating inside the brain [10] that varies with loop geometry and lead management from surgeon to surgeon.
Since a significant number of treatment-resistant patients are treated with such devices, a high-quality, low-power brain MRI could be valuable, although it is not currently available. For MRI of patients with DBS, some radiology groups have chosen to reduce the applied power by performing a limited MRI, [11, 12] whereas others have used high-power MRI on DBS patients claiming that they have a low adverse incidence track record [13, 14] . Note that a limited MRI may provide some protection against intra-or-extra cranial MRI burnsat the price of a significantly lower image quality. The safety and quality issues often discourages use of MRI for further MRI-guided neurosurgical interventionsand many surgeons opt to use CT instead. However, CT produces metal streaking artifacts with little cerebral tissue contrast or disease characterization compared to a high quality MRI. Our approach seem to provide adequate to high quality brain MRI sufficient for clinical diagnosis or additional neuro surgical planning.
We have developed a comprehensive brain MRI protocol utilizing both 2D and 3D MRI pulse sequences [15] [16] [17] 
II. Materials and Methods
Using an IRB approved protocol 10 medically refractory Parkinson's disease patients (mean age range: 55-78, 4 females) and 5 dystonia patients (mean age range: 21-56, 3 females) were imaged for 2 sessions, first one for pre-DBS stereotactic planning at high RF power (3 W/kg max) at 1.5 or 3T and the second session at 10-20 times lower RF power (0.1 W/kg max) at1.5T magnet (General Electric) for post-DBS electrode localization and screening for post-surgical complications. Various MRI sequences including T1 MPRAGE, FSET2, DTI and FSE IR sequences were used with prior sequence developmentsincluding modified MRI pulses for signal generation [13, 14] .White matter fiber tractography was performed by co-registeringdiffusion-weighted signal from fiber tracts on the underlying substrate images that were either low power 3D T1 or 2D T2 or 2D inversion recovery origin using the NordicICE Diffusion/DTI Module.
One neuro radiologist (RR) and one neurosurgeon (either EP or RA) compared the normal, high RF power images for pre-surgical planning and post surgical low power images with implanted metallic leads to assess potential post-surgical complications and lead location relative to desired target nuclei (Sub Thalamic Nuclei for Parkinson's and Globus Pallidal Nuclei or GPi for Dystonia). For assessing tissue contrast pre and post surgical images were compared using qualitative comparisons ofMRI appearance and tissue detectability for Globus Pallidus, Thalamus and Subthalamic Nucleus.The size of the signal void at each lead obliterating important structures were also noted since visualization of electrode/tissue interface is affected if the artifactual signal loss is substantial. However, the gray/white matter contrast is most important here as it localizes the electrode tip related to deep nuclei of interest.
III. Results and Discussion
There were no patient-related complications or device malfunctions during or after MRI. Low-power images on implant patients demonstrated tissue contrast comparable to images at high-power from non-implant sessions and considered adequate for radiologic interpretations.
All three readers concluded that low and high power images did not differ substantially in terms of tissue contrast and the extent of signal void due to metallic artifact from DBS tips was acceptable for diagnostic assessment or further surgical planning. However, low power images were reliable for stereotactic planning for 12/15 patients; while for the rest the neurosurgeons had to use additional landmarks for target verification due to suboptimal MR image quality. In all surgical sessions, in addition to using the MR images, real time patient feedbacks were also used during electrode advancement inside the brain parenchyma to confirm or adjust the electrode depth to ensure improved motor functionality and target response for best treatment outcomes.
Spin echo based low RF power MRI sequences provided acceptable image quality with minimum image blooming (enlargement, Fig 1B, 1C) while MPRAGE, a gradient echo based T1 sequence produced maximum signal void at the stimulator leads (Fig 1A) . The mean lead diameters visualized on images including the artifactual signal voids were 2.1 mm for 2D, 2.2 mm for 3D spin echo based sequences (T1, T2 and FLAIR) and 3.6-4.0 mm for 3D MPRAGE sequencewhen averaged over the entire patient group while the true diameters for the electrode tips was only about 1.3 mm.
The gray and white mattertissue contrasts for two dimensional low power T2 ( Figure 1C ) and Inversion Recovery MR images ( Figure 3) were adequate for stereotactic targeting while the 3D T1 MPRAGE or spin echo T1 images ( Figure 1A and 1B) could only be used to establish an indirect tissue mapping relationship using a typical stereotactic atlas. 
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Note that the detection and management of an infected DBS tip was successfully done using very low power 3D MRI FLAIR images (Figure 2 ). Routine 2D FLAIR MRI usually generates an unacceptable MRI heating and was not used. In Figure 3 high power pre-surgical inversion recovery MRI image is shown (3A) followed by post-left DBS implantationimage performed same day at low power (3B) and image from post-right DBS implantation (3C). Readers agreed that the high power (3A) and low power (3B, 3C) images have almost identical tissue contrast. In Figure 4 , the fractional anisotropies from DTI maps at basal ganglia level were independently measured by two readers and seemed to remain unchanged (for all 3 track overlays: MPRAGE or T2 or inversion recovery methods. The last two imaging methods delineated deep nuclear boundaries with significantly better G/W contrast. The high-power (pre-DBS) and low-power (post-DBS) DTI fiber tracts were qualitatively similar with minimal interference or artifactual distortion from the implanted leads. For deep brain stimulation treatments the knowledge about the pre-and-post surgical white matter connectivity could be very helpful. Low power MRI allows assessment of white matter integrity in patients with DBS and may be used to monitor the connectivity changes, alter stimulation parameters and minimize adverse side effects with DBS treatment. Due to the unavailability of low-power MR methods (at FDA approved level) many patients with implanted deep brain stimulators (DBS) do not benefit from all clinically useful MR sequences. The current practice of using atlas-based, indirect targeting of deep nuclei is imperfect. Recent reports claim diffusion tractography improves targeting accuracy also show significant variation when MRI is used to co-localize cingulate gyrus targets in depression(1) or thalamic targets for tremor (2) . Such issues may be resolved if advanced techniques like DTI can be routinely applied at FDA approved low-SAR level for patients with indwelling electrodes. We propose localizing DBS leads by T2 and FSEIR images that are more useful for delineating deep nuclear boundaries than conventional T1 MPRAGE followed by overlay of white matter fibers, all at low-power using the proposed low-power sequences. In the near future it may be possible to monitor such patients neurological function by low power functional MRI as demonstrated by functional MRI mapping forParkinson's patients with implanted DBS electrodes [4, 20] .
IV. Study Limitations
Low RF power MRIthat we have developed can minimize the potential for RF heating although it cannot completely eliminate a nominal amount of heating [15] [16] [17] .There is controversy about the iron composition and MRI contrast of deep brain nuclei as studied on a small patient population [19] and by other researchers. Producing adequate MRI tissue contrast for various neurosurgical targets is substantially challenging for low or high power MRI and robust MRI sequences need to be developed. Preservation of tissue contrast and identifying post-surgical lead locations as shown here should be applied to larger patient cohorts and experience from multiple neurosurgical practice sites are needed to appreciate the utility of low power MRI.
V. Conclusions
Diagnostic quality brain MRI can be performed with optimized, 2D or 3D sequences in patients with neuro implants within restrictive RF safety guidelines by significantly reducing tissue heating risks. Image quality and relative tissue contrasts comparable to clinical standards are achieved adjacent to DBS leads as well as in distal brain regions using low RF power spin echo based 2D and 3D sequences. The smallest artifactual blooming of stimulator leads happens in 2D and 3D FSE sequences while the highest signal void appears in the 3D MPRAGE sequence, being a gradient echo method.Low power (post-DBS, 1.5T) DTI fiber tracts were adequately visualized with minimal distortion or interference from the implanted leadssuggestive of postsurgical white matter fiber integrity in this patient population and may be used for future lead implantations or monitor existingDBS treatment.
